Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling.
- DOI
- 10.3390/ijms27209297
- Published
- 2026-10-20
- Container
- Int J Mol Sci
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27209297,
title = {Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling.},
author = {Jiang Y and Hu W and Yi L and Thacker M and Wu Q and Li Y and Gao E and Bian J and Do CW and Lam TC and Wong MS and Zhou L.},
year = {2026},
journal = {Int J Mol Sci},
doi = {10.3390/ijms27209297},
url = {https://doi.org/10.3390/ijms27209297}
}RIS
TY - JOUR TI - Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling. AU - Jiang Y AU - Hu W AU - Yi L AU - Thacker M AU - Wu Q AU - Li Y AU - Gao E AU - Bian J AU - Do CW AU - Lam TC AU - Wong MS AU - Zhou L. PY - 2026 JO - Int J Mol Sci DO - 10.3390/ijms27209297 UR - https://doi.org/10.3390/ijms27209297 ER -
APA
Y, J., W, H., L, Y., M, T., Q, W., Y, L., E, G., J, B., CW, D., TC, L., MS, W., & L., Z. (2026). Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling.. Int J Mol Sci. https://doi.org/10.3390/ijms27209297
Source records
- europe-pmc · retrieved 2026-11-10T09:03:54.082Z